Clik here to view.
Link between COVID-19 and prostate cancer raises possibility of new treatments
The overlapping biology identified between the molecular pathogenesis of COVID-19 and prostate cancer raises the possibility of repurposing drugs, including androgen deprivation therapy, for treating...
View ArticleMetastatic prostate cancer: cabazitaxel shows quality of life benefits over...
In addition to previously reported survival benefits, the taxane cabazitaxel improved quality of life in patients with advanced metastatic prostate cancer compared to the androgen signalling targeted...
View ArticleGut microbiome positively influences abiraterone response in prostate cancer
Abiraterone acetate (AA), an agent used in castrate-resistant prostate cancer, promotes a shift towards health-associated, anti-inflammatory gut commensal bacteria, finds a study in Nature...
View ArticleProlonged ADT use in prostate cancer increases CV mortality: A need for...
Prolonged androgen deprivation therapy (ADT) exposure was found to be associated with reduced cardiorespiratory fitness (CRF) and increased cardiovascular (CV) mortality. The study, published in JACC:...
View ArticleClik here to view.
Berlin pilot project brings precision care to the peripheries
An innovative network in Germany is giving men with advanced prostate cancer access to cutting-edge precision medicine – even if they live in remote areas. Patient organisations are wondering whether...
View ArticleCoffee may protect against prostate cancer
Drinking several cups of coffee every day may be linked to a lower risk of developing prostate cancer. The meta-analysis study, published in BMJ Open, (11 January) found that each additional daily cup...
View ArticleStudy brings mass biparametric MRI screening for prostate cancer a step closer
Using biparametric (bp) magnetic resonance imaging (MRI) to screen for prostate cancer identified twice as many clinically significant cancers as standard prostate-specific antigen (PSA) tests....
View ArticleClik here to view.
PSA population screening is back in favour: here’s why
Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s,...
View ArticleStudy suggests tackling loneliness could help reduce cancer in middle-aged men
Loneliness among middle-aged men is associated with increased risks of developing cancer. The longitudinal Finnish study, published in the May issue of Psychiatry Research, additionally found mortality...
View ArticleWake-up call to offer equal access to life-prolonging treatments in...
Less than one third of men with metastatic castration-sensitive prostate cancer (mCSPC) received established treatment intensification by 2018 that had been demonstrated to extend survival. The US...
View ArticleLow risk prostate cancer: real-world data reveals high rates of switching...
Over half of men initially managed with active surveillance (AS) for ‘low risk’ prostate cancer switch within four years to definitive treatments (e.g., surgery or radiation therapy). The Canadian...
View ArticleTackling drug resistance: how our commensal bacteria can hinder or help
Response to therapeutics can differ widely from patient to patient, with some gaining highly significant survival benefits from a therapy that in others elicits no response at all. Patients who respond...
View ArticleNew prostate cancer blood test combining PSA with epigenetic test could...
A non-invasive prostate cancer combination test has been shown to have a positive predictive value of 93%*, meaning that out of 100 patients testing positive for prostate cancer 93 will truly have the...
View ArticlePlant-based diets cut risk of prostate cancer progression and recurrence by...
Prostate cancer patients who consume the highest intakes of plant-based foods lower their risk of progression and recurrence. The study, abstract 392 presented at the 2023 American Society of Clinical...
View ArticleCardiorespiratory fitness reduces risk of developing and dying from cancer
Higher levels of cardiorespiratory fitness may reduce the incidence and mortality of specific cancers in men. The Swedish male cohort study, published online in JAMA Open Network, June 29, found that...
View ArticleClik here to view.
Reversing the rising trend in prostate cancer mortality in Poland
Between 2015 and 2020, age-standardised prostate cancer mortality rates rose by an estimated 18% in Poland, reflecting an increase in deaths from 4,876 to 5,748 over that period. This trend was in...
View ArticleIncreasing cardiorespiratory fitness reduces risk of prostate cancer
Increasing cardiorespiratory fitness rates by an average 3% a year or more is linked to a 35% reduced risk of men developing prostate cancer in comparison to those whose fitness levels declined by 3%...
View Article
